Analyst projections place possible approval in late 2027 or 2028, but those are estimates, not confirmed dates
It is a small synthetic molecule, not a peptide
These may include reduced soreness or tenderness at injury sites, improved digestion if the peptide is being used for gut-related concerns, and a general sense of reduced systemic inflammation
This product has not been evaluated by regulatory authorities for the diagnosis, treatment, cure, or prevention of any disease.Always consult a qualified healthcare provider before beginning any new health protocol, especially if you are pregnant, nursing, have a medical condition, or are taking prescription medication
GLY-200 (oral pharmacologic duodenal exclusion drug) decreases appetite, increases satiation, and reduces food intake in patients with type 2 diabetes